Related Experiment Video
Updated: Nov 28, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Pediatric onco-nephrology: time to spread the word : Part I: early kidney involvement in children with malignancy
Arwa Nada1, Jennifer G Jetton2
1Division of Nephrology, Department of Pediatrics, Le Bonheur Children's Hospital & Saint Jude Research Hospital, The University of Tennessee Health Science Center, TN, Memphis, USA. anada@uthsc.edu.
Insights
Pediatric onco-nephrology is emerging due to novel cancer therapies like CAR-T cells, posing unique kidney challenges. This growing field addresses cancer survivors
Area of Science:
- Pediatric Nephrology
- Oncology
- Cancer Therapeutics
Background:
- Onco-nephrology is a growing subspecialty in adult practice.
- Pediatric nephrologists increasingly manage malignancy-related kidney issues.
- Lack of specialized expertise in pediatric onco-nephrology exists.
Purpose of the Study:
- Highlight the growing challenges in pediatric onco-nephrology.
- Emphasize the need for specialized expertise in managing kidney-related toxicities from novel cancer therapies.
- Advocate for the formal recognition of pediatric onco-nephrology as a subspecialty.
Main Methods:
- Review of current literature on cancer therapies and their nephrotoxicities.
- Analysis of the evolving landscape of pediatric oncology treatments.
- Discussion of the impact of new therapies like CAR-T cell therapy on kidney function.
Main Results:
- Novel cancer therapies, including CD19-targeted chimeric antigen receptor T cell (CAR-T) therapy, present unique kidney side effects.
- Improved cancer survival rates lead to a higher incidence of chronic kidney disease in survivors.
- Pediatric nephrologists face increasing complexity in managing treatment-related kidney complications.
Conclusions:
- Pediatric onco-nephrology requires dedicated expertise to address complex kidney issues in childhood cancer patients and survivors.
- The field is expanding due to advancements in cancer treatment and improved patient outcomes.
- Formalizing pediatric onco-nephrology as a subspecialty is crucial for optimal patient care.
Abstract:
Onco-nephrology has been a growing field within the adult nephrology scope of practice. Even though pediatric nephrologists have been increasingly involved in the care of children with different forms of malignancy, there has not been an emphasis on developing special expertise in this area. The fast pace of discovery in this field, including the development of new therapy protocols with their own kidney side effects and the introduction of the CD19-targeted chimeric antigen receptor T cell (CAR-T) therapy, has introduced new challenges for general pediatric nephrologists because of the unique effects of these treatments on the kidney. Moreover, with the improved outcomes in children receiving cancer therapy come an increased number of survivors at risk for chronic kidney disease related to both their cancer diagnosis and therapy. Therefore, it is time for pediatric onco-nephrology to take its spot on the expanding subspecialties map in pediatric nephrology.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant III: Nursing Management
Acute Kidney Injury III: Clinical Manifestations
Nephrons
Kidney Transplant II: Surgical Procedure

